Skip to main content
NCBI home page
Annals of the Rheumatic Diseases logoLink to Annals of the Rheumatic Diseases
. 1991 Oct;50(10):731–734. doi: 10.1136/ard.50.10.731

Immune functions and inflammatory reactions in HLA-B27 positive subjects.

R Tertti 1, P Toivanen 1
PMCID: PMC1004543  PMID: 1958101

Full text

PDF
731

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aho K., Ahvonen P., Lassus A., Sievers K., Tilikainen A. HL-A antigen 27 and reactive arthritis. Lancet. 1973 Jul 21;2(7821):157–157. doi: 10.1016/s0140-6736(73)93109-7. [DOI] [PubMed] [Google Scholar]
  2. Armstrong R. D., Panayi G. S., Welsh K. I. Histocompatibility antigens in psoriasis, psoriatic arthropathy, and ankylosing spondylitis. Ann Rheum Dis. 1983 Apr;42(2):142–146. doi: 10.1136/ard.42.2.142. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Bengtsson A., Holmlund G., Kihlström E., Lindblom B. Lymphocyte stimulation in Reiter's syndrome. A comparative study between patients and normal controls with special reference to HLA-B27. Scand J Rheumatol. 1985;14(4):381–385. doi: 10.3109/03009748509102042. [DOI] [PubMed] [Google Scholar]
  4. Benjamin R., Parham P. Guilt by association: HLA-B27 and ankylosing spondylitis. Immunol Today. 1990 Apr;11(4):137–142. doi: 10.1016/0167-5699(90)90051-a. [DOI] [PubMed] [Google Scholar]
  5. Bevan M. J. Antigen recognition. Class discrimination in the world of immunology. Nature. 1987 Jan 15;325(6101):192–194. doi: 10.1038/325192b0. [DOI] [PubMed] [Google Scholar]
  6. Breur-Vriesendorp B. S., Dekker-Saeys A. J., Ivanyi P. Distribution of HLA-B27 subtypes in patients with ankylosing spondylitis: the disease is associated with a common determinant of the various B27 molecules. Ann Rheum Dis. 1987 May;46(5):353–356. doi: 10.1136/ard.46.5.353. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Brewerton D. A., Hart F. D., Nicholls A., Caffrey M., James D. C., Sturrock R. D. Ankylosing spondylitis and HL-A 27. Lancet. 1973 Apr 28;1(7809):904–907. doi: 10.1016/s0140-6736(73)91360-3. [DOI] [PubMed] [Google Scholar]
  8. Bucknall R., Leirisalo-Repo M., Laitinen O., Jones J. V. Antibody producing capacity to the bacteriophage phi X174 in yersinia arthritis. Ann Rheum Dis. 1987 Dec;46(12):883–888. doi: 10.1136/ard.46.12.883. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Cavender D., Ziff M. Anti-HLA-B27 antibodies in sera from patients with gram-negative bacterial infections. Arthritis Rheum. 1986 Mar;29(3):352–357. doi: 10.1002/art.1780290307. [DOI] [PubMed] [Google Scholar]
  10. Chen J. H., Kono D. H., Yong Z., Park M. S., Oldstone M. M., Yu D. T. A Yersinia pseudotuberculosis protein which cross-reacts with HLA-B27. J Immunol. 1987 Nov 1;139(9):3003–3011. [PubMed] [Google Scholar]
  11. Christiansen F. T., Hawkins B. R., Dawkins R. L. Immune function in ankylosing spondylitics and their relatives: influence of disease and HLA B27. Clin Exp Immunol. 1978 Aug;33(2):270–275. [PMC free article] [PubMed] [Google Scholar]
  12. Ciccone E., Colonna M., Viale O., Pende D., Di Donato C., Reinharz D., Amoroso A., Jeannet M., Guardiola J., Moretta A. Susceptibility or resistance to lysis by alloreactive natural killer cells is governed by a gene in the human major histocompatibility complex between BF and HLA-B. Proc Natl Acad Sci U S A. 1990 Dec;87(24):9794–9797. doi: 10.1073/pnas.87.24.9794. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Ebringer A., Baines M., Ptaszynska T. Spondyloarthritis, uveitis, HLA-B27 and Klebsiella. Immunol Rev. 1985 Aug;86:101–116. doi: 10.1111/j.1600-065x.1985.tb01140.x. [DOI] [PubMed] [Google Scholar]
  14. Geczy A. F., Alexander K., Bashir H. V., Edmonds J. A factor(s) in Klebsiella culture filtrates specifically modifies an HLA-B27 associated cell-surface component. Nature. 1980 Feb 21;283(5749):782–784. doi: 10.1038/283782a0. [DOI] [PubMed] [Google Scholar]
  15. Granfors K., Jalkanen S., Lindberg A. A., Mäki-Ikola O., von Essen R., Lahesmaa-Rantala R., Isomäki H., Saario R., Arnold W. J., Toivanen A. Salmonella lipopolysaccharide in synovial cells from patients with reactive arthritis. Lancet. 1990 Mar 24;335(8691):685–688. doi: 10.1016/0140-6736(90)90804-e. [DOI] [PubMed] [Google Scholar]
  16. Granfors K., Jalkanen S., von Essen R., Lahesmaa-Rantala R., Isomäki O., Pekkola-Heino K., Merilahti-Palo R., Saario R., Isomäki H., Toivanen A. Yersinia antigens in synovial-fluid cells from patients with reactive arthritis. N Engl J Med. 1989 Jan 26;320(4):216–221. doi: 10.1056/NEJM198901263200404. [DOI] [PubMed] [Google Scholar]
  17. Granfors K., Viljanen M., Tiilikainen A., Toivanen A. Persistence of IgM, IgG, and IgA antibodies to Yersinia in yersinia arthritis. J Infect Dis. 1980 Apr;141(4):424–429. doi: 10.1093/infdis/141.4.424. [DOI] [PubMed] [Google Scholar]
  18. Hammer R. E., Maika S. D., Richardson J. A., Tang J. P., Taurog J. D. Spontaneous inflammatory disease in transgenic rats expressing HLA-B27 and human beta 2m: an animal model of HLA-B27-associated human disorders. Cell. 1990 Nov 30;63(5):1099–1112. doi: 10.1016/0092-8674(90)90512-d. [DOI] [PubMed] [Google Scholar]
  19. Isomäki H., Nissilä M., Koota K., Martio J., Tiilikainen A. Letter: HL-A 27 and rheumatoid arthritis. Lancet. 1974 Nov 16;2(7890):1212–1213. doi: 10.1016/s0140-6736(74)90858-7. [DOI] [PubMed] [Google Scholar]
  20. Ivanyi P. Dysfunction of HLA-B27. Scand J Rheumatol Suppl. 1990;87:51–69. doi: 10.3109/03009749009097058. [DOI] [PubMed] [Google Scholar]
  21. Kijlstra A., Luyendijk L., van der Gaag R., van Kregten E., Linssen A., Willers J. M. IgG and IgA immune response against klebsiella in HLA-B27-associated anterior uveitis. Br J Ophthalmol. 1986 Feb;70(2):85–88. doi: 10.1136/bjo.70.2.85. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Koivuranta-Vaara P., Repo H., Leirisalo M., Kiistala U., Osterman T., Vapaatalo H. Enhanced neutrophil migration in vivo HLA B27 positive subjects. Ann Rheum Dis. 1984 Apr;43(2):181–185. doi: 10.1136/ard.43.2.181. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Leirisalo M., Repo H., Tiilikainen A., Kosunen T. U., Laitinen O. Chemotaxis in yersinia arthritis. HLA-B27 positive neutrophils show high stimulated motility in vitro. Arthritis Rheum. 1980 Sep;23(9):1036–1044. doi: 10.1002/art.1780230911. [DOI] [PubMed] [Google Scholar]
  24. Linssen A., Feltkamp T. E. B27 positive diseases versus B27 negative diseases. Ann Rheum Dis. 1988 May;47(5):431–439. doi: 10.1136/ard.47.5.431. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Meri S., Partanen J., Leirisalo-Repo M., Repo H. Complement activation and HLA-B27. Ann Rheum Dis. 1988 Mar;47(3):210–214. doi: 10.1136/ard.47.3.210. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Merilahti-Palo R., Söderström K. O., Lahesmaa-Rantala R., Granfors K., Toivanen A. Bacterial antigens in synovial biopsy specimens in yersinia triggered reactive arthritis. Ann Rheum Dis. 1991 Feb;50(2):87–90. doi: 10.1136/ard.50.2.87. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Miller C., Russell A. S. The generation of superoxide anions by polymorphonuclear leucocytes from patients with ankylosing spondylitis in response to the stimulant f-met-leu-phe. Clin Exp Rheumatol. 1986 Apr-Jun;4(2):135–137. [PubMed] [Google Scholar]
  28. Mäkelä A. L., Eerola E., Lehtonen O. P., Ruuska P., Lantto R. Erythrocyte C3b receptors in juvenile rheumatoid arthritis. N Engl J Med. 1983 Sep 15;309(11):673–673. doi: 10.1056/NEJM198309153091123. [DOI] [PubMed] [Google Scholar]
  29. Nikbin B., Brewerton D. A., James D. C., Hobbs J. R. Diminished mixed lymphocyte reaction in ankylosing spondylitis, relatives, and normal individuals all with HL-A 27. Ann Rheum Dis. 1976 Feb;35(1):37–39. doi: 10.1136/ard.35.1.37. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Pease C. T., Fennell M., Brewerton D. A. Polymorphonuclear leucocyte motility in men with ankylosing spondylitis. Ann Rheum Dis. 1989 Jan;48(1):35–41. doi: 10.1136/ard.48.1.35. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Repo H., Jättelä M., Leirisalo-Repo M., Hurme M. Production of tumour necrosis factor and interleukin 1 by monocytes of patients with previous Yersinia arthritis. Clin Exp Immunol. 1988 Jun;72(3):410–414. [PMC free article] [PubMed] [Google Scholar]
  32. Repo H., Leirisalo-Repo M., Gripenberg M., Koskimies S., Kontiainen S., Laitinen O. Yersinia arthritis, immune functions and histocompatibility antigens. Acta Pathol Microbiol Immunol Scand C. 1986 Dec;94(6):245–252. doi: 10.1111/j.1699-0463.1986.tb02119.x. [DOI] [PubMed] [Google Scholar]
  33. Repo H., Leirisalo-Repo M. Immune function in patients with previous yersinia arthritis: lymphocyte responses to PHA and Staphylococcus aureus strain Cowan I. Acta Pathol Microbiol Immunol Scand C. 1986 Feb;94(1):39–43. doi: 10.1111/j.1699-0463.1986.tb02087.x. [DOI] [PubMed] [Google Scholar]
  34. Repo H., Leirisalo-Repo M., Koskimies S. Effects of HLA-B27 positive and negative sera on migration of polymorphonuclear leukocytes in vitro. Clin Exp Rheumatol. 1988 Jul-Sep;6(3):227–231. [PubMed] [Google Scholar]
  35. Repo H., Leirisalo-Repo M., Skurnik M., Tiilikainen A. Neutrophil function and HLA-B27. Superoxide production and yersinicidal activity of neutrophils from patients with previous yersinia arthritis. Med Biol. 1984;62(2):91–94. [PubMed] [Google Scholar]
  36. Repo H., Leirisalo M., Tiilikainen A., Laitinen O. Chemotaxis in yersinia arthritis. In vitro stimulation of neutrophil migration by HLA--B27 positive and negative sera. Arthritis Rheum. 1982 Jun;25(6):655–661. doi: 10.1002/art.1780250608. [DOI] [PubMed] [Google Scholar]
  37. Rola-Pleszczynski M., Paré C., Camerlain M. HLA-B27 positive juvenile rheumatoid arthritis: altered lymphocyte responses to mitogens and low cytotoxic activity. Clin Immunol Immunopathol. 1982 Jul;24(1):102–110. doi: 10.1016/0090-1229(82)90093-9. [DOI] [PubMed] [Google Scholar]
  38. Rosenbaum J. T. Why HLA-B27: an analysis based on two animal models. Ann Intern Med. 1981 Feb;94(2):261–263. doi: 10.7326/0003-4819-94-2-261. [DOI] [PubMed] [Google Scholar]
  39. Rösler M., Bellaire W., Gressnich N., Giannitsis D., Jarovici A. HLA antigens in schizophrenia, major depressive disorder, and schizoaffective disorder. Med Microbiol Immunol. 1983;172(1):57–65. doi: 10.1007/BF02123678. [DOI] [PubMed] [Google Scholar]
  40. Sargent C. A., Dunham I., Trowsdale J., Campbell R. D. Human major histocompatibility complex contains genes for the major heat shock protein HSP70. Proc Natl Acad Sci U S A. 1989 Mar;86(6):1968–1972. doi: 10.1073/pnas.86.6.1968. [DOI] [PMC free article] [PubMed] [Google Scholar]
  41. Schwimmbeck P. L., Yu D. T., Oldstone M. B. Autoantibodies to HLA B27 in the sera of HLA B27 patients with ankylosing spondylitis and Reiter's syndrome. Molecular mimicry with Klebsiella pneumoniae as potential mechanism of autoimmune disease. J Exp Med. 1987 Jul 1;166(1):173–181. doi: 10.1084/jem.166.1.173. [DOI] [PMC free article] [PubMed] [Google Scholar]
  42. Spies T., Blanck G., Bresnahan M., Sands J., Strominger J. L. A new cluster of genes within the human major histocompatibility complex. Science. 1989 Jan 13;243(4888):214–217. doi: 10.1126/science.2911734. [DOI] [PubMed] [Google Scholar]
  43. Stieglitz H., Fosmire S., Lipsky P. Identification of a 2-Md plasmid from Shigella flexneri associated with reactive arthritis. Arthritis Rheum. 1989 Aug;32(8):937–946. doi: 10.1002/anr.1780320802. [DOI] [PubMed] [Google Scholar]
  44. Tertti R. Polymorphonuclear leukocyte chemiluminescence response in HLA-B27 positive and negative arthritic patients. Rheumatol Int. 1989;8(6):279–282. doi: 10.1007/BF00270985. [DOI] [PubMed] [Google Scholar]
  45. Thomsen B. S., Jacobsen S. E., Nielsen H., Jakobsen B. K., Sørensen H. Normal distribution of complement C3b receptor (CR1) numbers on erythrocytes in blood donors: low levels are associated with HLA-B27. Complement. 1986;3(2):79–87. doi: 10.1159/000467883. [DOI] [PubMed] [Google Scholar]
  46. Toivanen A., Lahesmaa-Rantala R., Vuento R., Granfors K. Association of persisting IgA response with yersinia triggered reactive arthritis: a study on 104 patients. Ann Rheum Dis. 1987 Dec;46(12):898–901. doi: 10.1136/ard.46.12.898. [DOI] [PMC free article] [PubMed] [Google Scholar]
  47. Viitanen A. M., Arstila T. P., Lahesmaa R., Granfors K., Skurnik M., Toivanen P. Application of the polymerase chain reaction and immunofluorescence techniques to the detection of bacteria in Yersinia-triggered reactive arthritis. Arthritis Rheum. 1991 Jan;34(1):89–96. doi: 10.1002/art.1780340114. [DOI] [PubMed] [Google Scholar]
  48. Vuento R., Eskola J., Leino R., Koskimies S., Viander M. IgM, IgG, and IgA synthesis in vitro in persons suffering from yersinia arthritis and in patients with ankylosing spondylitis. Ann Rheum Dis. 1984 Apr;43(2):186–191. doi: 10.1136/ard.43.2.186. [DOI] [PMC free article] [PubMed] [Google Scholar]
  49. Warmold A., van den Wall Bake L., Peeters A. J., van der Ark A., Daha M. R., Cats A., van Es L. A. Immunoglobulin synthesis by peripheral blood lymphocytes in patients with ankylosing spondylitis. J Rheumatol. 1988 Sep;15(9):1410–1414. [PubMed] [Google Scholar]
  50. Williams K. M., Raybourne R. B. Demonstration of cross-reactivity between bacterial antigens and class I human leukocyte antigens by using monoclonal antibodies to Shigella flexneri. Infect Immun. 1990 Jun;58(6):1774–1781. doi: 10.1128/iai.58.6.1774-1781.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  51. van Bohemen C. G., Grumet F. C., Zanen H. C. Identification of HLA-B27M1 and -M2 cross-reactive antigens in Klebsiella, Shigella and Yersinia. Immunology. 1984 Aug;52(4):607–610. [PMC free article] [PubMed] [Google Scholar]
  52. van Bohemen C. G., Nabbe A. J., Dinant H. J., Grumet F. C., Landheer J. E., Zanen H. C. Lack of serologically defined arthritogenic Shigella flexneri cell envelope antigens in post-dysenteric arthritis. Immunol Lett. 1986 Oct;13(4):197–201. doi: 10.1016/0165-2478(86)90055-6. [DOI] [PubMed] [Google Scholar]

Articles from Annals of the Rheumatic Diseases are provided here courtesy of BMJ Publishing Group

RESOURCES